Patent Assignment
Reel/Frame 053846/0249
Assignment of Assignor's Interest
Recorded: 2020-09-22
Pages: 4
Assignor
WEIDANZ, JON
Executed: 2018-05-31
Assignee
ABEXXA BIOLOGICS, INC.
NANOFAB BUILDING, BOX 19072, ARLINGTON, TEXAS, 76019
Covered Properties
(5)
Methods and Compositions for Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen in Cancer
Application:
16/103,764 →
Publication:
US 2019/0071502
Antibodies and Methods of Use Thereof
Application:
16/877,335 →
Publication:
US 2020/0291127
Antibodies and Methods of Use Thereof
Application:
16/877,346 →
Publication:
US 2020/0291128
Antibodies and Methods of Use Thereof
Application:
16/877,352 →
Publication:
US 2020/0325244
Antibodies and Methods of Use Thereof
Application:
16/877,368 →
Publication:
US 2020/0291116
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Nov 15, 2019
From: ABEXXA BIOLOGICS, INC.
To: BOEHRINGER INGELHEIM VENTURE FUND USA, INC.
Reel/Frame 051016/0081 →
Merger
Jan 6, 2022
From: ABEXXA BIOLOGICS, INC.
To: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Reel/Frame 058584/0680 →
Assignment of Assignor's Interest
Nov 1, 2022
From: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 061615/0332 →